2027 ICD-10-CM Diagnosis Code E26Hyperaldosteronism
E26 is a non-billable ICD-10-CM category code for hyperaldosteronism, so it cannot be submitted on claims. Use a more specific code from this category instead, such as E26.01, E26.02, E26.09, and E26.1.
Code Identity
Code Classification
Specific Coding for HyperaldosteronismOverview
Non-specific codes like E26 require more characters. Use one of these billable codes instead:
E26.0 for Primary hyperaldosteronism
Use E26.01 for Conn's syndrome
Use E26.02 for Glucocorticoid-remediable aldosteronism
Use E26.09 for Other primary hyperaldosteronism
Use E26.1 for Secondary hyperaldosteronism
E26.8 for Other hyperaldosteronism
Use E26.81 for Bartter's syndrome
Use E26.89 for Other hyperaldosteronism
Use E26.9 for Hyperaldosteronism, unspecified
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to E26: its own notes plus those printed at block E20-E35 and Chapter 4. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Notes
General instructions on how these codes are used.
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name E26, its category, or a range that includes it.
Code First 1
These codes say to code first a condition named in the note, and E26 is one of the conditions named.
- G63 Polyneuropathy in diseases classified elsewhere
Notes 1
These notes mention E26.
- Chapter 4 (E00-E89) Endocrine, nutritional and metabolic diseasesAll neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere. names E16-E31, which includes this code
Clinical InformationClinical
Hyperaldosteronism
a condition caused by the overproduction of aldosterone. it is characterized by sodium retention and potassium excretion with resultant hypertension and hypokalemia.
Patient EducationClinical
Adrenal Gland Disorders
Your adrenal glands are two small organs that sit on top of each kidney. The adrenal glands make different types of hormones you need to stay alive and healthy. Hormones are chemicals that travel in your bloodstream and control how different parts of your body work.
The full article covers:
- What are adrenal glands?
- What are adrenal gland disorders?
- What causes adrenal gland disorders?
- How are adrenal gland disorders diagnosed?
- What are the treatments for adrenal gland disorders?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Code HistoryHistory
Questions About E26Overview
What is the ICD-10 code for hyperaldosteronism?
E26 is the ICD-10-CM category for hyperaldosteronism, but it is a non-billable header: claims need a more specific code from this category, listed on this page.
Is E26 (Hyperaldosteronism) a billable code?
No. This is a category header that groups the codes for hyperaldosteronism, and headers cannot be submitted on claims. Claims for hyperaldosteronism need a more specific code from this category, such as E26.01, E26.02, and E26.09.
Can E26 be reported with N64.3?
Not as a rule. The Excludes1 note at block E20-E35, which applies to E26, lists "galactorrhea (N64.3)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).